We are pleased to introduce the first in a series of IR Procedure “Starter Kits.” These are very basic visual overviews of common procedures designed by the RFS for IR trainees. #SIRRFS#twittIR#IRad#OncoRad#RadRes#futurerads
𝗧𝗿𝗮𝗻𝘀𝗵𝗲𝗽𝗮𝘁𝗶𝗰 𝗮𝗿𝘁𝗲𝗿𝗶𝗮𝗹 𝗰𝗵𝗲𝗺𝗼𝗲𝗺𝗯𝗼𝗹𝗶𝘇𝗮𝘁𝗶𝗼𝗻 (𝗧𝗔𝗖𝗘) is a procedure that involves intra-arterial administration of chemotherapy, followed by an embolic agent, in order to induce necrosis of liver malignancy.
TACE is used as locoregional therapy for liver malignancies, both primary and metastatic. Listed here are the indications and contraindications of TACE.
Most patients undergoing TACE will first be presented at a multidisciplinary tumor conference, where the latest imaging will be reviewed. A discussion of their staging will direct them toward the most suitable therapy. Key imaging is multiphasic CT.
The procedure itself is performed under fluoroscopy, where an interventional radiologist will carefully select the vessels which supply the target lesion and treat them with a mixture of drug-eluting beads and contrast. Visual monitoring of the entire delivery process is key.
Following the procedure, the patient will be monitored in post-op for nausea and pain. Same-day discharge is typical. Moving forward, it will be increasingly important to compare TACE efficacy and safety against segmental ablation with treatments like Y-90.